Physician profile
Eric L Wee
NPI 1710037197
$970.27
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $209 · 2021: $336 · 2022: $118.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $200.75 | 2019-2022 | |
| Amgen INC. | $100.37 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.33 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $75.85 | 2021 | |
| Fidia Pharma USA INC. | $70.53 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $62.37 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.32 | 2020-2021 | |
| Eisai INC. | $50.91 | 2021 | |
| Hikma Pharmaceuticals USA | $50.71 | 2019-2020 | |
| Amarin Pharma, INC. | $41.18 | 2020-2021 | |
| Opko Pharmaceuticals, LLC | $25.70 | 2019 | |
| Pacira Therapeutics, INC. | $25.22 | 2020 | |
| Janssen Biotech, INC. | $24.80 | 2019 | |
| Vifor Pharma, INC. | $23.33 | 2020 | |
| Lilly USA, LLC | $22.23 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21.30 | 2019 | |
| Genzyme Corporation | $18.50 | 2019 | |
| Novo Nordisk INC | $17.87 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.